Results of a French external quality assessment program for Epstein Barr virus serology

Diagn Microbiol Infect Dis. 2024 Jul;109(3):116345. doi: 10.1016/j.diagmicrobio.2024.116345. Epub 2024 May 11.

Authors

Julien Lupo¹, Aurélie Truffot², Raphaële Germi², Anne-Karen Faure³, Patrice Morand², Elizabeth Francois-Burg⁴

Affiliations

¹ Univ. Grenoble Alpes, CEA, CNRS, CAID IBS, CHU Grenoble Alpes, Laboratoire de Virologie, 38000 Grenoble, France. Electronic address: [email protected].
² Univ. Grenoble Alpes, CEA, CNRS, CAID IBS, CHU Grenoble Alpes, Laboratoire de Virologie, 38000 Grenoble, France.
³ Univ. Grenoble Alpes, CHU Grenoble Alpes, Laboratoire de Virologie, 38000 Grenoble, France.
⁴ Délégation scientifique, ANSM, Saint-Denis, France.

PMID: 38759433
DOI: 10.1016/j.diagmicrobio.2024.116345

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral / blood
Epstein-Barr Virus Infections* / diagnosis
Epstein-Barr Virus Infections* / immunology
France
Herpesvirus 4, Human* / immunology
Humans
Serologic Tests* / methods
Serologic Tests* / standards

Substances

Antibodies, Viral